Autoimmune means your immune system is attacking your own body. Normally, your immune system can tell the difference between your own cells and foreign invaders like bacteria or viruses. In an autoimmune condition, that ability breaks down, and immune cells begin targeting healthy tissue as if it were a threat. An estimated 8% of the U.S. population has an autoimmune disease, and researchers recognize between 80 and 150 distinct autoimmune conditions.
How the Immune System Turns on Itself
Your immune system runs on recognition. Specialized cells constantly scan the body, checking whether the proteins they encounter belong to you or to something foreign. This ability to recognize and leave your own tissues alone is called self-tolerance. It develops early in life, as immune cells that would react against your own body are normally eliminated or deactivated before they can cause harm.
In autoimmune disease, self-tolerance fails. Immune cells that should have been filtered out survive and become active. They produce autoantibodies, which are immune proteins that lock onto your own tissues instead of invaders. Depending on which tissues those autoantibodies target, the result can be inflammation in your joints, damage to your thyroid, destruction of the coating around your nerves, or harm to virtually any organ system. The specific disease you develop depends on where the attack is focused.
What Causes Autoimmune Disease
No single thing causes autoimmunity. It takes a combination of genetic susceptibility and an environmental trigger. Autoimmune diseases run in families, meaning certain gene variants make some people more vulnerable. But genes alone aren’t enough. Something in the environment, often a viral infection, a chemical exposure, or another external stressor, appears to flip the switch in people who already carry the genetic risk.
This two-hit model explains why autoimmune diseases can seem to appear suddenly after a period of illness, stress, or environmental change. Your genes load the gun; the environment pulls the trigger.
Why Women Are Affected Far More Often
Four out of every five people diagnosed with an autoimmune disease are female. That ratio has puzzled researchers for decades, but a discovery from Stanford University has offered a compelling explanation. It centers on something unique to female biology: the way cells shut down one of their two X chromosomes.
Every cell in a female body randomly inactivates one X chromosome to avoid getting a double dose of its genes. This silencing process relies on a molecule called Xist and more than 80 associated proteins. Researchers found that the immune system sometimes produces autoantibodies against those very proteins. People with autoimmune diseases had autoantibodies targeting dozens of Xist-associated proteins, while people without autoimmune disease did not. The Xist complex alone doesn’t cause autoimmune disease, but it may help trigger it in people who are already vulnerable, which could explain why the female-to-male ratio is so heavily skewed.
Common Autoimmune Diseases and What They Target
Each autoimmune disease is defined by where the immune system directs its attack. Some target a single organ, while others affect multiple systems throughout the body.
- Rheumatoid arthritis primarily attacks the joints, usually on both sides of the body symmetrically. It can also affect skin, eyes, lungs, heart, and blood vessels.
- Lupus targets connective tissue in almost any organ or system, which is why its symptoms are notoriously wide-ranging and unpredictable.
- Psoriasis drives rapid skin cell turnover, causing thick, scaly patches. When it also inflames the joints, it becomes psoriatic arthritis.
- Sjögren’s syndrome primarily affects moisture-producing glands in the eyes and mouth, though it can also involve joints, lungs, and muscles.
- Type 1 diabetes destroys the insulin-producing cells in the pancreas.
- Multiple sclerosis damages the protective coating around nerve fibers in the brain and spinal cord.
Symptoms That Cut Across Conditions
Because autoimmune diseases involve widespread immune activation, many of them share a core set of early symptoms: persistent fatigue that isn’t relieved by rest, joint pain or stiffness, low-grade fevers, and general malaise that comes and goes. Many conditions also flare and remit, meaning symptoms intensify for weeks or months, then partially or fully recede before returning.
These overlapping, vague symptoms are a major reason autoimmune diseases are hard to pin down early. A person might feel exhausted and achy for months without any clear explanation, cycling through possible diagnoses before the pattern becomes clear.
Why Diagnosis Takes So Long
Getting a definitive autoimmune diagnosis takes an average of about four years, even in countries with advanced healthcare systems. The delay happens for several reasons. Early symptoms like fatigue and joint pain overlap with dozens of other conditions. No single test confirms most autoimmune diseases. And symptoms often wax and wane, making them easy to dismiss.
The most common initial screening tool is the antinuclear antibody (ANA) test, which checks whether your immune system is producing antibodies against your own cell components. The test is highly sensitive, catching about 98% of people who have an autoimmune connective tissue disease. But it has low specificity, around 75%, meaning it also comes back positive in many healthy people or in people with unrelated conditions. Up to 50% of certain populations can test positive for ANA without having an autoimmune disease. A positive ANA result is a starting point, not a diagnosis. Further testing narrows down which specific autoantibodies are present, helping identify the exact condition.
How Autoimmune Diseases Are Treated
Autoimmune diseases are currently managed rather than cured. The central goal of treatment is to calm the overactive immune response enough to reduce symptoms and prevent organ damage, without suppressing the immune system so much that you become vulnerable to infections.
Traditional treatment relies on medications that broadly dampen immune activity. Over the past two decades, a newer class of drugs called biologics has transformed management for many conditions. These medications are more targeted. Instead of suppressing the whole immune system, they block specific inflammatory signaling molecules or deactivate particular types of immune cells that drive the attack. Biologics are now used across a wide range of autoimmune conditions, including rheumatoid arthritis, psoriasis, inflammatory bowel disease, lupus, and certain types of vasculitis.
Treatment is highly individualized. Some people achieve near-complete symptom control, while others cycle through multiple medications before finding one that works. Flares can still occur even with effective treatment, and many people need ongoing monitoring and medication adjustments over the course of their lives. The practical reality for most patients is learning to manage a chronic condition: tracking symptoms, recognizing flare patterns, and working with a care team over the long term.